Healthcare Companies in Sweden

At Alex Therapeutics, we design and develop CE-certified Digital Therapeutics (DTx) products. We’re a pioneer within our field, combining Cognitive Behavioural Therapy (CBT) and Acceptance and Commitment Therapy (ACT) with Artificial Intelligence to provide patients with highly personalized and effective care. The Alex Platform allows for the easy development of new products, and we see incredible potential in future verticals such as obesity, depression, oncology, and more. We’re always looking for great partners and co-workers. Please send us an email at partner@alextherapeutics.com to get in touch.

Elsa Science strives to contribute to a future where chronic disease is minimized. Where people who are diagnosed can reach optimal health sooner and live a new life faster, and to its full potential. Elsa Science was established in 2017 by a team of influential scientists and award winning designers who have a passion to improve the health of people living with chronic disease. Driven by science, self-reported patient data, and individualized care, and through meaningful content and design, Elsa Science aims to make science accessible and put it in the hands of the people living with a chronic disease. Providing motivation and education through two tools - the Elsa Science Self-care app and Clinical Dashboard, bring patients and families closer together with healthcare providers through seamless data sharing. Our digital solution provides a powerful communication tool for a greater good, to better manage the illness, improve healthcare, and empower the individual to proactively self-care.

Elypta is a Swedish molecular diagnostics company focused on reducing cancer mortality through early detection. Elypta is pioneering a metabolism-based liquid biopsy and measures the GAGome – system biomarkers of tumor metabolism. Machine learning algorithms are then used to detect signatures of cancer noninvasively. Elypta is advancing a broad clinical program across different cancers with the first indication expected to be early detection of recurrence in renal cell carcinoma. Several years of research in Nielsen lab at Chalmers University of Technology in Gothenburg, Sweden led to the founding of Elypta in May 2017 by Francesco Gatto and Jens Nielsen.

Gesynta Pharma's drug candidate GS-248 is in clinical phase II development for the treatment of endometriosis – a painful, chronic inflammatory disease that affects about 10 percent of women of reproductive age. Endometriosis often leads to severely reduced quality of life and current drug treatments are inadequate for many patients. Gesynta Pharma aims to exploit the full potential of microsomal prostaglandin E synthase-1 (mPGES-1) as a pharmacological target by developing products in areas of unmet medical need where mPGES-1 inhibition provides clear benefits compared to current therapy. The company's next drug candidate, GS-073, is ready to enter clinical phase I in 2023. Gesynta Pharma bases its R&D on research from the Karolinska Institutet. Major shareholders include Industrifonden, Hadean Ventures, Linc, and a number of successful life science entrepreneurs.

Gradientech is a Swedish biotech and diagnostics company dedicated to support the modern microbiology lab with state-of-the-art solutions to facilitate the workflow with time-critical samples. Our product QuickMIC® is an ultra-rapid system for antibiotic susceptibility testing (AST) of positive blood culture samples from sepsis patients. QuickMIC® is a scalable system with each instrument module analysing one sample against multiple antibiotics, well-suited for small and larger clinical laboratories. MIC values are reported in as short as 2 hours, making it more rapid than any other diagnostic system for phenotypic AST on the market. Gradientech’s technology combines microfluidics with live cell imaging to study cell responses in a linear concentration gradient. Our technology is a perfect match for many biological applications. Gradientech holds an ISO13485 certification.

MedBeat is a medical technology company establishing a modern solution to accurately monitor your heart activity everywhere and anytime during your everyday life. We are developing medical devices and software, with the purpose of monitoring and enhancing cardiac health.

Navinci (formerly Olink Bioscience), has a proud history of inventing analytic technologies for nucleic acids and proteins, identifying commercial opportunities and bringing successful products to the market to serve scientist in research and drug development. Founded in 2004 on the breakthrough innovations by Ulf Landegren and colleagues at Uppsala University, the company has directly marketed a wide range of products including the Duolink in situ protein detection product line, which was acquired by Sigma-Aldrich in 2016. Navinci has also launched several daughter companies such as Olink Proteomics (noted Nasdaq NY: OLK) for high-throughput protein analysis in blood, Q-linea (noted on Nasdaq) focusing on counteracting antibiotic resistance in sepsis, and Halogenomics (acquired by Agilent) in target selection for next generation sequencing. Moreover, the company has outlicensed IP rights to several leading international life science companies. Navinci holds a broad and growing patent portfolio utilizing oligonucleotide-conjugated antibodies for detection of proteins and their interactions. From our base in Uppsala, Sweden, Navinci contributes to improve human health by serving scientist with sharp and tailored tools to study proteins and their interactions in order to understand human biology and develop better drugs.

Intelligent Implants is a medical device company operating at the intersection of digital medicine and orthopedics. We develop innovative electrotherapeutic orthopedic devices to address significant unmet clinical needs. The company's SmartFuse® platform is a wirelessly enabled, active implant technology that uses an array of electrodes to stimulate, control, and monitor bone growth. Our mission is to leverage SmartFuse to develop a pipeline of smart orthopedic implants that can reduce healing times, engage patients & surgeons, enable digital surgery/robotics and ultimately improve outcomes for millions of patients.

Docly is enabling clinicians to provide digital healthcare 24/7. We are proud of being a spin-off from the pioneering digital health care provider; Min Doktor established 2013. Docly was founded by a doctor and created for doctors. The strong partnership challenges Docly to push its limits and drive innovation in the industry of digital healthcare globally. Doclys´ "Time To Care" concept has contributed to more than 1,5 million consultations. Hence becoming a client of Docly automatically enables the client to be part of leading the development and change the way we care about people around the world. Today. And tomorrow.

At Doctrin, we are passionate about improving healthcare. We strive to make patients healthier and happier, and healthcare professionals more effective at work. We achieve this by providing digital tools automating and simplifying as much of the patient journey as possible, for as many patients as possible. The Doctrin team has diverse experiences in software development, healthcare provision and management consulting. All of us share the passion to improve healthcare and we are dedicated to build an organization with strong culture and values.

Problems that occure after open abdominal surgery are both painful and difficult for clincians and patients. Scientific evidence shows that the right surgical technique can reduce complications after open surgical procedures. Research shows that it is essential to follow best practice and clinical guidelines to reduce the risk of complications, such as incisional hernia and deep wound infections. Today more than 20% of patients develops hernia after abdominal surgery. We at Suturion want to be part of preventing these unnecessary complications by assisting clinicians with technologies to adhere to best practice prinicples of abdominal closure. During training and practice surgeon Gabriel Börner often encountered complications to closure of the abdomen after surgery. Most notably wound infections and incisional hernias. This experience, together with a growing body of scientific evidence and research showing that a evidence-based surgical technique can reduce these complications planted an idea that a device could help surgeons prevent hernias instead of repairing them. Suturion AB was founded in 2018 by Gabriel Börner and medtech engineer Mats O. Christensson and LU Holding AB. Suturion have during the last years filed several patent applications, performed extensive market analysis and pre-clinical reserach. Gabriel Börner MD is a frequent speaker at medical congresses and travels the world presenting his scientific research and findings. During 2022 Suturion are conducting a clinical trial which is an important step toward the regulatory pathway for CE and FDA approval.

Coala Life (Nasdaq First North: COALA) is a Swedish medical technology and life science company focusing on heart diagnostics and digital health. The company has developed a portfolio of solutions based on the Coala, a patented and commercial service for remote monitoring and self-screening of heart sounds and ECG. The Coala is available direct to consumers and the Coala Pro is offered to healthcare professionals to enable smart, digital cardiac assessments. CE and FDA cleared. We make it possible for everyone to monitor their heart. Cardiovascular diseases are one of the leading causes of death around the world. A key contributor is late diagnosis. Coala Life was founded as a research project in 2004 and physicians and Swedish researchers to change that. In 2015, Coala Life was formed as a company and the solutions are here that replace an analogue device from the 18th century, the stethoscope, with a digital solution that records both heart sounds, ECG, and heart frequency. A unique solution that listens, measures and analyses heart data with smart algorithms, which allows many heart diseases to be detected and treated early. A series of patents and unique technology is the base this unique Swedish system. www.coalalife.com

Bokadirekt is an online booking provider and marketplace for primarily the health and beauty sector.

Doktor.se is a digital healthcare provider that helps with counseling, booking doctors, distance care, recipes, referrals, and more.

Mevia provides intelligent solutions to increase the quality of medical treatments. We develop solutions for improving adherence - the greatest challenge in medical treatments. We manage to do this by increasing the patient support and providing personal adherence feedback in real-time. We work closely with our clients to develop innovative packaging and IT solutions that provide patients with the best possible experience.

Games that make a difference. We create meaningful games that nudge people – our playtients – into healthy habits. Our games and characters act as companions on the journey to better health.

With us you can meet a doctor online

Njord Medtech® AB was founded by Barbro Cagner - former nurse, union representative, and Deputy Head at Sahlgrenska Radiology. Njord aims to secure a patient and user-centric healthcare system via fit for purpose product- and service development. The company has been incubated within the Sahlgrenska Hospital since 2016, and incorporated in 2019.

Oatly is a company built on the idea of change. We exist to make it easy for people to eat better and live healthier lives without recklessly taxing the planet’s resources in the process. This is why we come to work every day. Headquartered in Malmö, Sweden, the Oatly brand is available in more than 20 countries across Europe, North America and Asia. Visit oatly.com to learn more.

OmMej develops a digital platform used for mapping and monitoring children's mental health.

Call Knut is a “check-in buddy” for the elderly™